The Annals
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 27 July 2004, www.theannals.com, DOI 10.1345/aph.1E010a.
 The Annals of Pharmacotherapy: Vol. 38, No. 9, pp. 1545. DOI 10.1345/aph.1E010a
© 2004 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Correction: cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression

Published Online, July 27, 2004. www.theannals.com, DOI 10.1345/aph.1E010a

In the printed version of this article on cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression,1 the Euro symbol ({euro}) failed to appear in the text and tables in all cases where there should have been an indication of monetary value. We regret this inconvenience to readers; however, a corrected version appears in The Annals Online.—ED

Footnotes

Letters are subject to review prior to acceptance. They should address areas related to pharmacy practice, research, or education, or articles recently published. Corrections of previously published material also are accepted. Letters are limited to no more than five authors. In cases where adverse drug effects are described, the Naranjo ADR probability scale should be used to determine the likelihood that the adverse effect was drug-related (Clin Pharmacol Ther 1981;30:239-45). Text: limit 500 words. References: limit 5. Art: limit 1 table or figure.

References

  1. Hemels MEH, Kasper S, Walter E, Einarson TR. Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression.Ann Pharmacother 2004;38:954-60. DOI 10.1345/aph.1E010[Abstract/Free Full Text]




This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

homecopy help contact us subscription past issues search current issue